Viewing nowCombinationAdbon Plus D Tablet
Sodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.

MFDS item code 201202770 · Approved 2012.04.09 · Insurance code 647803630
Treatment of osteoporosis in postmenopausal women and men
This medication is used for the treatment of osteoporosis in postmenopausal women and men.
Take 1 tablet of this drug (70 mg/2800 IU or 70 mg/5600 IU) once weekly in the morning with plenty of water, at least 30 minutes before consuming any food, beverages, or other medications (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The optimal duration of treatment has not been established. The safety and efficacy of this drug for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation after 3~5 years of treatment should be considered. Patients who discontinue treatment should be reassessed regularly for fracture risk. Other beverages or food, including mineral water and barley tea, and medications may reduce the absorption of alendronate (see “Interactions”). Taking food within 30 minutes after taking this drug, or at the same time, may reduce the absorption of alendronate and decrease its efficacy. This drug should be taken upon arising in the morning and swallowed with plenty of water (170∼230 mL) to facilitate rapid delivery of the medication to the stomach and reduce the potential for esophageal irritation. Do not lie down for at least 30 minutes after taking this drug and until after the first food of the day. Do not take this drug at bedtime or before arising for the day. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients with inadequate calcium and vitamin D intake from food should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to be provided to patients (4)). Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Once-weekly administration of this drug provides a week’s supply of vitamin D at 400 IU and 800 IU per day. If a patient taking 1 tablet of this drug forgets to take it on the scheduled day, take 1 tablet the next morning, then resume taking it on the previously scheduled day and continue once weekly thereafter. However, do not take 2 tablets on the same day. Administration in elderly patients (65 years and older): No dose adjustment is necessary. Administration in patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min); however, use of this drug is not recommended in patients with severe renal impairment (creatinine clearance less than 35 mL/min) because there is insufficient clinical experience.
Pediatric and adolescent patients (under 18 years): Safety and efficacy in pediatric and adolescent patients have not been established.
This medication may irritate the gastrointestinal mucosa and can cause esophageal adverse reactions such as esophagitis, esophageal ulcers, and esophageal erosion. Take with plenty of water and avoid lying down for at least 30 minutes after administration. If you experience difficulty swallowing, chest pain, or heartburn, stop taking it immediately and consult a doctor. This medication should not be administered to patients with esophageal motility disorders, those who cannot sit or stand upright for more than 30 minutes, those with hypersensitivity to the components, those with hypocalcemia, and patients with specific genetic metabolic disorders. During treatment, side effects such as gastrointestinal disturbances, musculoskeletal pain, headache, dizziness, taste disturbances, and skin rashes may occur, so caution is needed. Particularly, when taken with calcium supplements or antacids, absorption may be impaired, so maintain a minimum interval of more than 30 minutes between doses. Pregnant or breastfeeding women should take it cautiously based on a doctor's judgment, and it should not be used in children. It is not recommended for patients with severely impaired kidney function, and conditions of hypocalcemia or vitamin D deficiency should be treated first. Take this medication upon waking on an empty stomach with plenty of water and strictly follow the administration method, including not lying down for a certain period after taking it. Long-term use may increase the risk of low-energy bone fractures, so regular check-ups are necessary according to the doctor's instructions. In the event of an overdose, gastrointestinal irritation symptoms and hypocalcemia may occur, so contact a medical institution immediately, and do not induce vomiting. This medication should be kept out of reach of children, and transferring it to another container can cause quality degradation, so caution is advised.
esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, hemorrhage, dysphagia, odynophagia, retrosternal pain, heartburn, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, vomiting, abdominal distension, gastritis, musculoskeletal pain, muscle cramps, headache, dizziness, taste disturbance, rash, erythema, anastomotic ulcer, urticaria, angioedema, hypersensitivity reaction, myalgia, lethargy, weakness, fever, symptoms of hypocalcemia, peripheral edema, oropharyngeal ulcer, gastric ulcer, duodenal ulcer, jaw necrosis, joint edema, low-energy fractures of the femoral head and other bones, dizziness, vertigo, itching, hair loss, Stevens-Johnson syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal, nasopharyngitis
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, avoid direct sunlight and store it at room temperature between 1°C and 30°C.
White to light yellow rectangular tablet
4 tablets (4 tablets/PTP*1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
Sodium Alendronate Hydrate · Cholecalciferol Concentrate Powder
Prescription medication · Combination
Korea Union Pharm Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Farm Gen Science Co., Ltd.
CombinationSodium Alendronate Hydrate 91.37mg · Cholecalciferol Concentrate Powder 53.33mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.